Commercial Truck Accident and Pharmacy Lien: A Case Study

James Wong — Founder & Pharmacist, LienScripts | February 13, 2026 | 9 min read

A semi-truck rear-end collision on a highway caused severe lumbar and cervical injuries, multiple fractures, and a 20-month recovery arc. The pharmacy lien provided uninterrupted medication access throughout — and the MERIT report functioned as expert clinical documentation in a high-value, multi-defendant case against the driver and trucking company.

Case Background

Note: This is a fictionalized case study based on composite facts. Names and identifying details are not real. The clinical details represent typical medication patterns for this injury type.

Commercial truck accident cases occupy a distinct tier in personal injury litigation. The defendants are institutional — a trucking company, a commercial insurer, and sometimes a cargo owner or maintenance contractor — and they bring institutional defenses. Defense firms with experience in federal motor carrier regulations, black box data, and commercial vehicle standards take these cases seriously, and they expect the plaintiffs' bar to do the same.

One area where commercial truck defense consistently probes for weakness is the medical evidence. Trucking company insurers employ in-house medical review teams, retain independent medical examiners early, and scrutinize treatment records for gaps, inconsistencies, and overtreatment arguments. A complete, coherent, continuously documented medication record is not a nice-to-have in these cases — it is a foundational piece of the damages evidence.

This case study follows Patricia, a 47-year-old woman who was rear-ended by a fully loaded semi-truck on a highway, sustained catastrophic orthopedic and spinal injuries, and required more than 20 months of active medical treatment. Her pharmacy lien with LienScripts began the week of hospital discharge and ran without interruption through the conclusion of her active treatment period.

[!KEY] Commercial truck accident cases attract institutional defenses with significant resources. A 20-month pharmacy record with zero gaps, organized into a MERIT report, functions as a clinical expert document that anticipates and preempts the independent medical examiner's overtreatment arguments before the IME report is even written.

The Accident

Patricia was traveling in the right lane of a highway when a fully loaded semi-truck traveling at highway speed rear-ended her vehicle. The impact was catastrophic — her vehicle was pushed forward approximately 180 feet before coming to rest against a guardrail.

Emergency responders extracted Patricia from the vehicle. She was airlifted to a Level I trauma center.

The Injuries

Trauma evaluation revealed a severe injury picture across multiple body systems:

• Lumbar spine: L3-L4 and L4-L5 disc herniations with moderate-to-severe canal compromise; L4 compression fracture with 40% anterior height loss
• Cervical spine: C5-C6 disc herniation with right-sided foraminal stenosis; cervical strain with ligamentous injury
• Right femur fracture: mid-shaft fracture requiring intramedullary nail fixation
• Right wrist fracture: distal radius fracture, treated with ORIF (open reduction internal fixation with plate and screws)
• Multiple rib fractures: right ribs 4 through 8, treated conservatively; right-sided pulmonary contusion noted on CT
• Closed head injury with brief loss of consciousness: cognitive symptoms and post-concussive headaches persisting through month 4

Patricia was hospitalized for 12 days before discharge to a rehabilitation facility. She spent an additional three weeks in inpatient rehabilitation before transitioning to outpatient care.

The treatment trajectory was projected from the outset to be lengthy. Her spine surgeon estimated a 12 to 18 month conservative management period for the lumbar and cervical injuries, with surgical intervention as a likely eventual outcome. The orthopedic injuries — femur and wrist — added their own recovery arcs.

The Defendants

Investigation identified two primary defendants:

The truck driver: The driver had a commercial driver's license in good standing and had not exceeded hours-of-service limits at the time of the accident. However, data retrieved from the truck's electronic logging device and event data recorder showed the driver had applied the brakes fewer than two seconds before impact, suggesting inattention rather than mechanical failure.

The trucking company: The company employed the driver, maintained the vehicle, and held the commercial motor carrier authority. The company's insurer — a large commercial trucking carrier — was the primary financial defendant. Federal motor carrier regulations (FMCSA) created a basis for direct claims against the company for negligent hiring, supervision, and dispatching, in addition to vicarious liability for the driver's actions.

Patricia's attorney filed against both defendants and issued a litigation hold to preserve the driver's employment records, training files, prior violations, and the event data recorder data.

The Pharmacy Lien from Discharge

Patricia's attorney enrolled her in a LienScripts pharmacy lien the week of hospital discharge. Her initial post-discharge regimen was immediately complex, reflecting the multi-system nature of her injuries.

Phase 1: Acute and Post-Acute (Months 1–4)

Opioid pain management — oxycodone ER 20mg BID with oxycodone IR 5mg PRN: Patricia's post-discharge pain was severe, consistent with multiple orthopedic fractures and severe spinal disc injuries. Her pain management physician managed the opioid regimen with structured dosing intervals and documented monthly pain assessments. The ER/IR combination allowed for baseline coverage with breakthrough capability. The prescription record documented the controlled, monitored nature of the opioid regimen throughout this phase.

Diclofenac 75mg BID: Anti-inflammatory for the lumbar and cervical disc herniations and soft tissue injury.

Cyclobenzaprine 5mg TID: Muscle relaxant for lumbar and cervical paraspinal spasm. Documented at this dose through month 3.

Gabapentin 300mg TID, titrated to 600mg TID: Initiated at week 3 when the radicular symptoms from the lumbar and cervical herniations were established. Titrated upward at month 2. This medication became the backbone of Patricia's neuropathic pain management for the duration of the case.

Levetiracetam 500mg BID: Post-traumatic seizure prophylaxis following the closed head injury with loss of consciousness. Continued through month 4 and then tapered and discontinued by the neurologist with documented clinical rationale.

Omeprazole 40mg daily: Gastrointestinal protection given the long-term NSAID use in the context of post-injury stress.

Ondansetron 4mg PRN: Nausea management during the initial opioid adjustment period.

[!KEY] The controlled and documented opioid taper across Phase 1 is significant evidentiary material. It demonstrates appropriate prescribing under physician supervision — precisely the opposite of what a commercial trucking insurer's independent medical examiner will typically allege when reviewing a complex post-injury opioid record. A clean taper, documented month by month in the pharmacy record, is a powerful preemptive counter to the IME's overtreatment narrative.

Phase 2: Subacute and Surgical Evaluation (Months 4–12)

As the acute phase resolved, several clinical transitions occurred and were documented in the pharmacy record.

Opioid taper completed (month 4): Patricia's opioid use was tapered and discontinued at month 4. The pharmacy record showed clean, declining fill frequency consistent with the taper protocol. After month 4, there were no opioid fills — a detail that directly undercuts any defense argument that the pain management regimen was inappropriate.

Gabapentin 600mg TID — continued: The neuropathic radicular component from both the lumbar and cervical herniations did not resolve after the opioid taper. Gabapentin remained the primary analgesic for the neuropathic component throughout the case.

Duloxetine 60mg daily — added at month 5: Patricia's pain management physician added duloxetine as a dual-mechanism adjunct — an SNRI with established efficacy for neuropathic pain and musculoskeletal pain, and which also addressed the emerging mood component of chronic pain. The clinical annotation in the prescription record explained the dual indication.

Sumatriptan 100mg PRN — added at month 3, continued through month 8: Post-concussive headaches that evolved into a migraine pattern were managed with sumatriptan on an as-needed basis. Utilization tracked at approximately 8 doses per month through month 5, declining to 4 doses per month by month 8, and resolving without further fills by month 10. This utilization curve was documented in the pharmacy record and corroborated the neurologist's clinical notes about headache resolution trajectory.

Tizanidine 4mg QHS — substituted for cyclobenzaprine at month 4: As the acute spasm phase transitioned to chronic myofascial pain, the treating physician switched to tizanidine for its longer-acting nocturnal spasm and sleep-disruption benefits. The switch was documented with a prescriber note explaining the clinical rationale.

Compounded topical — lumbar and cervical application: A compounded diclofenac and baclofen topical was added at month 5 to provide localized anti-inflammatory and antispasm effect at the lumbar and cervical injury sites, supplementing the systemic medications and reducing systemic NSAID load. Continued through month 14.

Phase 3: Surgical and Post-Surgical (Months 12–20)

At month 12, Patricia's lumbar spine surgeon determined that conservative management had reached its clinical ceiling. The L4 compression fracture had not spontaneously reduced, and the L3-L4 and L4-L5 disc herniations were producing persistent motor weakness in the right lower extremity. Lumbar fusion surgery — L3 through L5 — was performed at month 13.

The surgical phase generated a distinct second arc in the pharmacy record:

Post-surgical opioid bridge — oxycodone IR 5mg every 4 hours PRN: A short-course post-operative opioid was prescribed for the two weeks immediately following the lumbar fusion surgery. The pharmacy record documented initiation and a two-week taper that was complete by week 3 post-operatively. No opioid fills appeared outside this window.

Celecoxib 200mg daily: Prescribed by the spine surgeon for the post-fusion recovery period. COX-2 selective NSAIDs are sometimes preferred by spine surgeons during the early fusion consolidation period for their analgesic profile.

Continued gabapentin 600mg TID and duloxetine 60mg daily: Both medications continued uninterrupted through the surgical period and into post-operative recovery.

Tizanidine 4mg BID: Increased from QHS to BID dosing during the acute post-surgical phase for muscle spasm management.

Continued compounded topical: Remained in the regimen for the cervical component, which had not been surgically addressed.

At month 18, cervical disc herniation at C5-C6 required surgical intervention — a single-level anterior cervical discectomy and fusion (ACDF). The pharmacy record documented a similar post-operative arc for the cervical surgery, with appropriate short-course opioid use and clean taper.

By month 20, Patricia had reached maximum medical improvement on her pharmacological regimen. The record showed gabapentin and duloxetine as ongoing medications, with the compounded topical discontinued at month 18 following the ACDF.

The MERIT Report as Expert Clinical Documentation

Patricia's attorney prepared a demand package targeting both defendants. The MERIT report was submitted as a standalone exhibit — not simply as a pharmacy printout, but as an organized clinical narrative structured by treatment phase and injury track.

The report documented:

• The acute post-discharge regimen and the controlled opioid bridge with clean taper
• The subacute phase transitions, including the opioid discontinuation at month 4 and the addition of duloxetine
• The surgical phases for both lumbar fusion and cervical ACDF, each with their own documented post-operative medication arcs and clean opioid tapers
• The 20-month continuous record with zero gaps in medically necessary fills
• The ongoing medications at maximum medical improvement — establishing the foundation for future medical costs

The trucking company's insurer retained an independent medical examiner who opined that Patricia's treatment was excessive and that she had reached maximum medical improvement earlier than her treating physicians concluded. The MERIT report directly rebutted this opinion: the IME had no explanation for why a patient who had allegedly reached maximum medical improvement at month 12 underwent lumbar fusion at month 13 and cervical ACDF at month 18, and why her neuropathic medication regimen documented consistent ongoing clinical necessity through month 20.

[!KEY] In multi-defendant commercial trucking cases, the MERIT report functions as a clinical expert document that operates independently of the treating physicians' notes. It presents the medication record as an objective, time-stamped narrative that the defense cannot selectively edit — every fill, every taper, every surgical medication arc is documented in sequence.

The Settlement Waterfall

The case resolved through a multi-defendant mediated settlement. The settlement waterfall included:

• Attorney fees and litigation costs
• The pharmacy lien payoff — the full LienScripts lien amount for 20 months of medication coverage
• A Medicare set-aside allocation for future medical costs (Patricia was not yet Medicare-eligible, but a voluntary Medicare Set-Aside was structured as part of the settlement documentation)
• Patricia's net recovery

The pharmacy lien resolved cleanly at settlement, with the payoff negotiated as part of the overall lien and provider resolution process.

Key Takeaways for Attorneys

1. Enroll at discharge, not weeks later. In high-value truck accident cases, the pharmacy record starts on day one. Every week of delay at the beginning of the case represents documentation that the defense can argue was obtained outside the pharmacy lien program — or that the patient was managing without the medication.

2. Document opioid tapers meticulously. The trucking defense playbook includes challenging opioid prescribing as excessive. A pharmacy record showing a controlled taper completed on schedule, with no fills outside the prescribed period, is the most effective preemptive counter to that argument.

3. Two surgical phases require two distinct medication arcs. When a patient requires surgery for multiple injury sites at different times, the MERIT report should clearly delineate each surgical phase's medication record as a separate clinical episode. This prevents the defense from characterizing the second surgery's opioid use as a continuation of the first.

4. Future medical costs require present medication documentation. Patricia's ongoing gabapentin and duloxetine at maximum medical improvement directly supported the future medication cost component of her damages. Without the 20-month pharmacy record documenting the clinical necessity of these medications, the future cost argument would rest solely on physician testimony rather than documented treatment history.

Related Resources

• High-Value PI Medication Strategy
• Pharmacy Lien: No Out-of-Pocket Cost for Injured Patients
• Gabapentin vs. Pregabalin for Nerve Pain After Injury
• ACDF Cervical Fusion Medications and Pharmacy Lien
• Lumbar Fusion Medications and Pharmacy Lien
• Pharmacy Lien Reduction and Negotiation